鞘內泵市場規模、佔有率和成長分析:按產品類型、應用、最終用戶、組件、銷售管道和地區分類-2026-2033年產業預測
市場調查報告書
商品編碼
2069006

鞘內泵市場規模、佔有率和成長分析:按產品類型、應用、最終用戶、組件、銷售管道和地區分類-2026-2033年產業預測

Intrathecal Pumps Market Size, Share, and Growth Analysis, By Product Type (Constant Rate Pumps, Programmable Pumps), By Application, By End-User, By Component Focus, By Sales Channel, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2024 年全球鞘內幫浦市場價值為 3.371 億美元,預計到 2033 年將成長至 5.3655 億美元,而 2025 年為 3.5497 億美元,預測期(2026-2033 年)複合年成長率為 5.3%。

全球鞘內幫浦市場的發展動力源自於有效控制難治性慢性疼痛和痙攣的需求,透過標靶腦脊髓液給藥,顯著改善患者的生活品質。由於人口老化以及慢性肌肉骨骼和神經系統疾病盛行率的上升,對可植入式、可程式設計的鴉片類藥物、Baclofen和其他藥物輸送裝置的需求激增。這一市場成長反映了技術進步、更清晰的臨床指南以及增強的安全措施,這些都提升了醫療專業人員的信心。電池壽命、遙測技術和個人化給藥演算法的創新正在減少全身性鴉片類藥物的使用和住院次數,並因其有利的報銷條件而受到保險公司的關注。人工智慧在持續監測中的應用有望進一步改善患者預後,提高市場效率,為醫療設備製造商和製藥合作夥伴創造盈利機會。

全球鞘內幫浦市場的成長要素

慢性疼痛和痙攣的日益普遍顯著地推動了對標靶治療(包括鞘內幫浦)的需求。醫療專業人員認知到局部給藥在增強症狀控制和最大限度減少全身暴露的優勢。這種觀點正在加速鞘內療法在專科醫療機構治療方案中的應用,醫療機構也正在投資必要的培訓和基礎設施。隨著臨床醫生和患者對相關知識和意識的提高,轉診模式和治療方法選擇正發生顯著變化,轉向能夠提供長期鎮痛的醫療設備。因此,這一趨勢正透過增加手術量和擴大這些醫療設備的使用範圍來推動市場成長。

全球鞘內幫浦市場的限制因素

全球鞘內幫浦市場的成長受到高昂的部署和維修成本及其耗材的限制,這限制了許多醫療機構和病患的使用。許多預算有限的醫院和診所可能會優先選擇更經濟的治療方法或保守策略,而不是這些先進的系統。此外,植入手術和持續的程序設置也增加了額外的經濟負擔,這阻礙了保險公司和醫療機構採用這項技術。因此,當經濟因素是治療決策的首要考量時,尤其是在保險報銷不足以涵蓋相關成本的情況下,鞘內幫浦系統的推廣往往較為緩慢。

全球鞘內幫浦市場趨勢

全球鞘內幫浦市場正呈現出整合到個人化治療的強勁趨勢。這促使臨床醫生和製造商致力於為每位患者量身定做個人化的給藥方案,以適應其生理功能和疼痛模式。可程式設計儲液器、高響應性輸注演算法以及創新藥物-醫療設備組合的開發,使得個人化給藥方案的製定成為可能,並提高了患者的依從性。這種轉變促進了醫療設備工程師、神經科醫生和疼痛專家之間的合作,從而最佳化了患者選擇和長期管理策略。此外,保險公司和醫療服務提供者也越來越重視以病患療效和生活品質為中心的價值提案,不再採用統一的方法來支持全球各種慢性神經系統疾病的管理。

目錄

介紹

  • 調查目的
  • 市場定義和範圍

調查方法

  • 研究過程
  • 二級資料和一級資料的方法
  • 市場規模估算方法

執行摘要

  • 全球市場展望
  • 市場主要亮點
  • 細分市場概覽
  • 競爭環境概述

市場動態及展望

  • 總體經濟指標
  • 促進者和機會
  • 抑制因素和挑戰
  • 供給面趨勢
  • 需求面趨勢
  • 波特的分析和影響

關鍵市場分析

  • 關鍵成功因素
  • 影響市場的因素
  • 主要投資機會
  • 生態系測繪
  • 2025年市場魅力指數
  • PESTLE分析
  • 監理情勢

全球鞘內幫浦市場規模:依產品類型分類

  • 恆速泵浦
  • 可程式設計泵浦
  • 其他

全球鞘內幫浦市場規模:依應用領域分類

  • 疼痛管理
  • 痙攣管理
  • 其他

全球鞘內幫浦市場規模:依最終用戶分類

  • 醫院
  • 門診手術中心
  • 專科診所
  • 其他

全球鞘內幫浦市場規模:按組件分類

  • 嵌入式幫浦裝置
  • 鞘內導管
  • 其他

全球鞘內幫浦市場規模:依銷售管道分類

  • 直接向醫療機構銷售
  • 醫療設備銷售代理
  • 其他

全球鞘內幫浦市場規模:依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲國家
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

競爭資訊

  • 前五大公司對比
  • 主要公司2025年的市場定位
  • 主要市場公司採取的策略
  • 近期市場趨勢
  • 企業市場占有率分析,2025 年
  • 主要公司的完整公司簡介
    • 公司詳情
    • 產品系列分析
    • 按細分市場進行企業市佔率分析
    • 銷售收入年比比較(2023-2025 年)

主要公司簡介

  • Medtronic
  • Teleflex
  • Johnson & Johnson
  • Flowonix Medical
  • Tricumed Medizintechnik
  • Infusyn Therapeutics
  • ALZET
  • Cardiva
  • B. Braun
  • PRS Neurosciences
  • Avanos Medical
  • AIS Healthcare
  • Pentec Health
  • Hartley Medical
  • Mallinckrodt
  • Smiths Medical
  • Stryker
  • Boston Scientific
  • Abbott
  • Codman Neuro

結論與建議

簡介目錄
Product Code: SQMIG35A3863

Global Intrathecal Pumps Market size was valued at USD 337.1 Million in 2024 and is poised to grow from USD 354.97 Million in 2025 to USD 536.55 Million by 2033, growing at a CAGR of 5.3% during the forecast period (2026-2033).

The global intrathecal pumps market is driven by the need to effectively manage refractory chronic pain and spasticity through targeted drug delivery into the cerebrospinal fluid, significantly enhancing patient quality of life. As implantable, programmable devices that administer opioids, baclofen, and other medications, their demand has surged alongside aging populations and increased prevalence of chronic musculoskeletal and neurological conditions. The evolution of this market reflects technological advancements, clearer clinical guidelines, and enhanced safety measures that boost clinician confidence. Innovations in battery life, telemetry, and personalized dosing algorithms reduce systemic opioid use and hospital visits, gaining payer interest for favorable reimbursement. The integration of AI for continuous monitoring is set to further improve patient outcomes and streamline market efficiencies, creating lucrative opportunities for device manufacturers and pharmaceutical partners.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrathecal Pumps market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrathecal Pumps Market Segments Analysis

Global intrathecal pumps market is segmented by product type, application, end-user, component focus, sales channel and region. Based on product type, the market is segmented into Constant Rate Pumps, Programmable Pumps and Others. Based on application, the market is segmented into Pain Management, Spasticity Management and Others. Based on end-user, the market is segmented into Hospitals, Ambulatory Surgery Centers, Specialty Clinics and Others. Based on component focus, the market is segmented into Implantable Pump Devices, Intrathecal Catheters and Others. Based on sales channel, the market is segmented into Direct Institutional Sales, Medical Device Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intrathecal Pumps Market

The rising prevalence of chronic pain and spasticity significantly fuels the demand for targeted therapies, including intrathecal pumps. Healthcare professionals recognize the benefits of localized drug delivery, which minimizes systemic exposure while enhancing symptom management. This perspective accelerates the integration of intrathecal therapy into treatment protocols at specialized facilities and prompts healthcare providers to invest in necessary training and infrastructure. As knowledge and awareness among both clinicians and patients grow, there is a noticeable shift in referral patterns and treatment choices towards devices that provide long-lasting relief. Consequently, this trend is propelling market growth through higher procedure volumes and increased use of these devices.

Restraints in the Global Intrathecal Pumps Market

The growth of the global intrathecal pumps market is hindered by the significant acquisition and maintenance costs tied to these devices and their consumables, which restrict access for numerous healthcare providers and patients. Many budget-limited hospitals and clinics may choose to prioritize more affordable treatment alternatives or conservative management strategies over these advanced systems. Furthermore, the requirement for specialized implantation procedures and continuous programming adds further financial pressure, discouraging both payers and providers from embracing this technology. Consequently, when economic factors are the primary focus in treatment decisions, the adoption of intrathecal systems tends to be sluggish, especially in environments where reimbursement mechanisms fall short of covering associated expenses.

Market Trends of the Global Intrathecal Pumps Market

The Global Intrathecal Pumps market is experiencing a robust trend toward personalized therapy integration, where clinicians and manufacturers focus on creating individualized delivery profiles that align with distinct patient physiology and pain patterns. The development of programmable reservoirs and responsive infusion algorithms, alongside innovative drug-device combinations, facilitates tailored dosing regimens and enhances patient adherence. This shift fosters collaboration among device engineers, neurologists, and pain specialists to refine patient selection and long-term management strategies. Furthermore, payers and providers are increasingly evaluating value propositions centered around patient outcomes and quality of life, steering away from generic approaches and supporting a diverse range of chronic neurological conditions globally.

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Intrathecal Pumps Market Size by Product Type & CAGR (2026-2033)

  • Market Overview
  • Constant Rate Pumps
  • Programmable Pumps
  • Others

Global Intrathecal Pumps Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Pain Management
  • Spasticity Management
  • Others

Global Intrathecal Pumps Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgery Centers
  • Specialty Clinics
  • Others

Global Intrathecal Pumps Market Size by Component Focus & CAGR (2026-2033)

  • Market Overview
  • Implantable Pump Devices
  • Intrathecal Catheters
  • Others

Global Intrathecal Pumps Market Size by Sales Channel & CAGR (2026-2033)

  • Market Overview
  • Direct Institutional Sales
  • Medical Device Distributors
  • Others

Global Intrathecal Pumps Market Size & CAGR (2026-2033)

  • North America (Product Type, Application, End-User, Component Focus, Sales Channel)
    • US
    • Canada
  • Europe (Product Type, Application, End-User, Component Focus, Sales Channel)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Application, End-User, Component Focus, Sales Channel)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Application, End-User, Component Focus, Sales Channel)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Application, End-User, Component Focus, Sales Channel)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Medtronic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Flowonix Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tricumed Medizintechnik
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Infusyn Therapeutics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ALZET
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiva
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PRS Neurosciences
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avanos Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AIS Healthcare
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pentec Health
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hartley Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mallinckrodt
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Smiths Medical
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Codman Neuro
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations